Mylan Pharma has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name ‘MyHep LVIR’ in India. The drug is an important addition to the company’s growing Hepato Care segment in India that gives it an opportunity to offer patients the potential to be cured through a transformative and simplified single tablet, once- daily treatment regimen. The launch of MyHep LVIRTM follows the launch of generic Sofosbuvir in India under the brand name MyHepTM in April, 2015. In September 2014, Mylan entered into a licensing and technology transfer agreement with Gilead that granted the former non-exclusive rights to manufacture and distribute generic Sofosbuvir and Ledipasvir/Sofosbuvir tablets in 101 developing countries, including India.
Leave a Reply